Immunome, Inc. Profile Avatar - Palmy Investing

Immunome, Inc.

Immunome, Inc., a biopharmaceutical company, discovers and develops antibody therapeutics for oncology and infectious disease. The company's lead oncology program includes IMM-ONC-01, which targets IL-38 tumor-derived immune checkpoint capable of promoti…

Biotechnology
US, Exton [HQ]

Document Reader

Click To Read:

DEF 14-A Proxies

Not a single DEF 14-A proxy doc.

10-K Filings

Not a single 10-K doc.

10-Q Filings

Not a single 10-Q doc.

LDA 1/2 Filings [Lobbying]

Not a single LDA doc.

End of IMNM's Analysis
CIK: 1472012 CUSIP: 45257U108 ISIN: US45257U1088 LEI: - UEI: -
Secondary Listings
IMNM has no secondary listings inside our databases.